期刊文献+

他扎罗汀和卡泊三醇治疗斑块状银屑病的比较 被引量:8

Comparative Study of Calcipotriol(0.005%) Ointment and Tazarotene(0.05% and 0.10%) Gel in the Treatment of Stable Plaque Psoriasis
原文传递
导出
摘要 目的观察比较他扎罗汀凝胶与卡泊三醇软膏治疗斑块状银屑病的疗效与安全性。方法60例斑块状银屑病患者分为3组:0.005%卡泊三醇组18例,早晚各外涂1次。0.1%和0.05%他扎罗汀组各21例,每晚外涂1次;各组疗程均为8周。结果治疗8周后,0.005%卡泊三醇软膏和0.1%他扎罗汀对皮损改善程度相当,优于0.05%他扎罗汀凝胶,差异有统计学意义(P<0.05);0.005%卡泊三醇软膏、0.1%他扎罗汀和0.05%他扎罗汀凝胶总有效率分别为83.33%、85.71%和76.19%,差异无统计学意义(P>0.05)。结论卡泊三醇软膏与他扎罗汀凝胶治疗斑块状银屑病安全有效。 Objective To observe the efficacy and safety of tazarotene gel and calcipotriol ointment in the treatment of plaque-type psoriasis.Methods 60 patients with plaque-type psoriasis were divided into three groups.18 patients were treated with calcipot riolointment topically twice a day for 8 weeks.21 patients were treated with 0.10% or 0.05% tazarotene gel topically once on night for 8 weeks respectively.Results After 8 weeks' treatment,the plaque improvement by using topical calcipotriol 0.005% ointment was comparable to tazarotene 0.1% gel,however,more than tazarotene 0.05% gel(P〈0.05);the total effective rates were 83.33%,85.71% and 76.19% respectively.No obvious differences were observed between the three groups(P〉0.05).Conclusion Tazarotene gel and calcipotriol ointment were safe and effective in therapy for plaque type psoriass.
作者 曹慧 韩洪方
出处 《中华全科医学》 2010年第4期455-456,共2页 Chinese Journal of General Practice
关键词 他扎罗汀 卡泊三醇 银屑病 药物评价 Tazarotene Calcipotriol Psoriasis Drug evalution
  • 相关文献

参考文献10

二级参考文献14

  • 1汪刚,刘效筠.他扎罗汀凝胶和卤米松乳膏联合治疗斑块型银屑病的疗效观察[J].中国皮肤性病学杂志,2005,19(2):124-124. 被引量:8
  • 2郭纶绪.氨茶碱与沙丁胺醇合用治疗寻常型银屑病[J].新药与临床,1996,15(2):114-115. 被引量:8
  • 3宋智琦 林熙然.外用莪术油霜剂治疗银屑病[J].中华皮肤科杂志,1998,31(2):124-125.
  • 4[1]Chandraratna RAS.Tazarotene-first of a new generation of receptor-selective retinoids. Br J Dermatol, 1996;135(Supp.149):18~25.
  • 5[2]Weinstein G, Jeffes E,et al.Tazarotene gel for the treatment of plaque psoriasis: a double-blind clinical study. J Invest Dermatol,1995;104:661.
  • 6[3]Marks R: Clinical safety of tazarotene in the treatment of plaque psoriasis. J Am Acad Dermatol, 1997;37:S25~S32.
  • 7张学军.皮肤性病学[M].北京:人民卫生出版社,1991.117-122.
  • 8Linden KG,Weinstein GD.Psoriasis:Current perspectives with an emphasis on treatment[J].Arch Dermatol,1998,134 (1):57 -60.
  • 9Menter A.Pharmacokineties and safety of tazarotene[J].J Am Acad Dermatol,2000,43(2):31 -35.
  • 10Lebwohl MG,Breneman DL,Goffe BS,et al.Tazaroten 0.1% gel plus conticosteroid in the treatment of plaque psoriasis[J].Am Acad Dermatol,1998,39:590-596.

共引文献23

同被引文献115

引证文献8

二级引证文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部